Abstract
Importance Alzheimer’s disease (AD) is a major health concern in the U.S., but most research has focused on older populations. Few studies investigate AD risk factors and cognitive function in young to early midlife adults.
Objective To examine whether key AD risk factors are associated with cognition before midlife.
Design, Setting, Participants Data from the National Longitudinal Study of Adolescent to Adult Health (Add Health) were analyzed. Participants were enrolled in 1994-95 (grades 7-12) and followed through 2018. We analyzed survey and biomarker data from Waves IV (median age 28) and V (median age 38).
Exposures Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) score, APOE ε4 status, Amyloid Tau and Neurodegeneration markers (ATN), including total Tau and Neurofilament light (NfL), high sensitivity C-reactive protein (hsCRP), Interleukin (IL)-1β, IL-6, IL-8, IL-10, and Tumor necrosis factor alpha (TNF-α).
Main Outcomes Immediate word recall, delayed word recall, and backward digit span.
Results We analyzed data separately in Wave IV (ranging from N=4,507 to N=11,449) and Wave V (ranging from N=529 to N=1,121). Approximately half were female. The CAIDE score was associated with all cognition measures in Wave IV. For example, among adults aged 24-34, each 1-point increase in CAIDE was associated with a 0.03 SD lower backward digit span score (95% CI: −0.04, −0.02). No significant associations were found between APOE ε4 and cognition. Total Tau was associated with immediate word recall in Wave V (β=-0.14, 95% CI: −0.24, −0.04). Wave IV hsCRP and IL-10 and Wave V IL-6, IL-1β and IL-8 were also associated with lower cognitive scores.
Conclusions Key risk factors for AD, including cardiovascular, ATN, and immune markers, are linked to cognitive function as early as ages 24-44, highlighting the need for early prevention in the US.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://addhealth.cpc.unc.edu/documentation/user-guides/
https://addhealth.cpc.unc.edu/
Funding Statement
This research was funded by P01HD31921 from NICHD, U01AG071448 and U01AG071450 from the NIA and R01AG057800 from NIA. Additional funding from NIH grants T32HD091058, P2CHD050924, P30AG066615.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of University of North Carolina at Chapel Hill and IRB of Columbia University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Minor editing to make text more concise, improve flow, and include significant associations that were previously not highlighted in the text. No changes to any of the analyses or results found in figures/tables. Improved formatting in the supplement.
Data Availability
All data produced in the present study will be available to Add Health Users in 2026.
